MedPath
NMPA Approval

Timolol Maleate Eye Drops

国药准字H20249113

October 22, 2024

Drug Information

马来酸噻吗洛尔滴眼液

眼用制剂

0.5%(5ml:25mg)(按C₁₃H₂₄N₄O₃S计)

化学药品

October 22, 2024

Company Information

Applicant Company

徐州经济技术开发区杨山路18号

Manufacturing Company

徐州经济技术开发区杨山路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

马来酸噻吗洛尔滴眼液 - NMPA 批准文号 | MedPath